Treatment Options for MODY Patients: A Systematic Review of Literature

Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY)

(2019) Yukio Horikawa et al.   Current Diabetes Reports

981-P: GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in HNF1A Diabetes

(2019) ALEXANDER S. CHRISTENSEN et al.   DIABETES

First Case Report of Maturity-Onset Diabetes of the Young Type 4 Pedigree in a Chinese Family

(2019) Mingqun Deng et al.   Frontiers in Endocrinology

Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy

(2019) F. Reilly et al.   DIABETIC MEDICINE

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

(2018) Maurizio Delvecchio et al.   ACTA DIABETOLOGICA

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

(2018) Pamela Bowman et al.   Lancet Diabetes & Endocrinology

ISPAD 2018 Consensus Guidelines: The diagnosis and management of monogenic diabetes in children and adolescents

(2018) Andrew T. Hattersley et al.   PEDIATRIC DIABETES

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial

(2018) Alexander Sidelmann Christensen et al.   BMJ Open

Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012

(2017) Maurizio Delvecchio et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features

(2017) Yukio Horikawa et al.   PEDIATRIC DIABETES

Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India

(2017) Mahesh Doddabelavangala Mruthyunjaya et al.   PLoS One

Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation

(2016) Souhaïra Ben Khelifa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Aberrant mRNA splicing of paired box 4 (PAX4) IVS7-1G>A mutation causing maturity-onset diabetes of the young, type 9

(2015) Jatuporn Sujjitjoon et al.   ACTA DIABETOLOGICA

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

(2015) Sabrina Prudente et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- Model

(2015) Jana Urbanova et al.   CURRENT PHARMACEUTICAL DESIGN

Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation

(2015) Ali J. Chakera et al.   DIABETES CARE

Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA 1c

(2015) Victoria L. Rudland et al.   DIABETES CARE

Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort

(2015) S. Bacon et al.   DIABETIC MEDICINE

Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young--Type 2 and Type 3

(2014) S. H. Ostoft et al.   DIABETES

Low Prevalence ofHNF1AMutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital: Table 1

(2014) Maurizio Delvecchio et al.   DIABETES CARE

The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort

(2014) Ali J. Chakera et al.   DIABETES CARE

Treatment of young patients with HNF1A mutations (HNF1A-MODY)

(2014) K. Raile et al.   DIABETIC MEDICINE

A Family with a Novel Termination Mutation in Hepatic Nuclear Factor 1α in Maturity-Onset Diabetes of the Young Type 3 Which Is Unresponsive to Sulphonylurea Therapy

(2014) S. Demol et al.   Hormone Research in Paediatrics

Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia

(2014) Anna M. Steele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)

(2014) M. Becker et al.   PEDIATRICS

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

(2013) Rochelle N. Naylor et al.   DIABETES CARE

Mody-3: Novel HNF1A Mutation and the Utility of Glucagon-Like Peptide (GLP)-1 Receptor Agonist Therapy

(2013) Maricor Docena et al.   Endocrine Practice

Risk Factors for Subclinical Atherosclerosis in Diabetic and Obese Children

(2013) Maria Felicia Faienza et al.   International Journal of Medical Sciences

TheHNF4AR76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype

(2013) Alexander J Hamilton et al.   JOURNAL OF MEDICAL GENETICS

Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies

(2013) Anna M. Steele et al.   PLoS One

Identification of Candidate Children for Maturity-Onset Diabetes of the Young Type 2 (MODY2) Gene Testing: A Seven-Item Clinical Flowchart (7-iF)

(2013) Michele Pinelli et al.   PLoS One

Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes

(2012) A. Bonnefond et al.   DIABETOLOGIA

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

(2012) B. M. Shields et al.   DIABETOLOGIA

Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene

(2012) Amélie Bonnefond et al.   PLoS One

Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications

(2011) M.P. Kyithar et al.   DIABETES & METABOLISM

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations

(2011) R. R. Kapoor et al.   DIABETOLOGIA

A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients

(2009) M. Shepherd et al.   DIABETIC MEDICINE

Mutations at the BLK locus linked to maturity onset diabetes of the young and  -cell dysfunction

(2009) M. Borowiec et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes

(2008) A. Molven et al.   DIABETES

Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion

(2008) S. Edfalk et al.   DIABETES

Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation

(2008) G. Spyer et al.   DIABETIC MEDICINE

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

(2008) Rinki Murphy et al.   Nature clinical practice. Endocrinology & metabolism